Terms: = Germ cell tumor AND TSC2, FLJ43106, 7249, ENSG00000103197, LAM, tuberin, TSC4 AND Treatment
47 results:
1. Targeting the EGFR pathway: An alternative strategy for the treatment of tuberous sclerosis complex?
Schachenhofer J; Gruber VE; Fehrer SV; Haider C; Glatter S; Liszewska E; Höftberger R; Aronica E; Rössler K; Jaworski J; Scholl T; Feucht M
Neuropathol Appl Neurobiol; 2024 Apr; 50(2):e12974. PubMed ID: 38562027
[TBL] [Abstract] [Full Text] [Related]
2. A study on molecular mechanism of Xihuang pill in the treatment of glioblastoma based on network pharmacology and validation in vitro and in vivo.
Xu HB; Chen XZ; Zhu SY; Xue F; Zhang YB
J Ethnopharmacol; 2024 Apr; 323():117675. PubMed ID: 38159819
[TBL] [Abstract] [Full Text] [Related]
3. Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways.
Wang S; Gu Z; Zhu L; Han Y; Yu H; Fang W; Han B
Chin Med J (Engl); 2023 Nov; 136(22):2712-2721. PubMed ID: 37749819
[TBL] [Abstract] [Full Text] [Related]
4. Primary mucosal melanomas of the urogenital tract: a clinical, pathological, and genetic nationwide survey of Danish patients 1990-2019.
Znaider VK; Mikkelsen LH; Jensen CFS; Sønksen J; Heegaard S
Scand J Urol; 2023 Aug; 58():52-59. PubMed ID: 37635444
[TBL] [Abstract] [Full Text] [Related]
5.
Xie J; Yang MR; Hu X; Hong ZS; Bai YY; Sheng J; Tian Y; Shi CY
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511135
[TBL] [Abstract] [Full Text] [Related]
6. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
Navale P; Chatterjee D; Itani M; Trikalinos NA
Virchows Arch; 2023 Aug; 483(2):167-175. PubMed ID: 37354253
[TBL] [Abstract] [Full Text] [Related]
7. Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine tumors and Metastases.
Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
[TBL] [Abstract] [Full Text] [Related]
8. Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data.
Boilève A; Faron M; Fodil-Cherif S; Bayle A; Lamartina L; Planchard D; Tselikas L; Kanaan C; Scoazec JY; Ducreux M; Italiano A; Baudin E; Hadoux J
Eur J Cancer; 2023 Jun; 186():122-132. PubMed ID: 37062210
[TBL] [Abstract] [Full Text] [Related]
9. [Tuberous sclerosis complex: diagnosis and current treatment].
Cerisola A; Cibils L; Chaibún ME; Pedemonte V; Rosas M
Medicina (B Aires); 2022 Aug; 82 Suppl 3():71-75. PubMed ID: 36054862
[TBL] [Abstract] [Full Text] [Related]
10. germline genetic biomarkers to stratify patients for personalized radiation treatment.
Deichaite I; Hopper A; Krockenberger L; Sears TJ; Sutton L; Ray X; Sharabi A; Navon A; Sanghvi P; Carter H; Moiseenko V
J Transl Med; 2022 Aug; 20(1):360. PubMed ID: 35962345
[TBL] [Abstract] [Full Text] [Related]
11. STAT3 suppresses the AMPKα/ULK1-dependent induction of autophagy in glioblastoma cells.
Bhattacharya S; Yin J; Yang C; Wang Y; Sims M; Pfeffer LM; Chaum E
J Cell Mol Med; 2022 Jul; 26(14):3873-3890. PubMed ID: 35670018
[TBL] [Abstract] [Full Text] [Related]
12. [Subependymal Giant cell Astrocytoma with Tuberous Sclerosis Complex(TSC-SEGA)].
Ichikawa T; Niida Y
No Shinkei Geka; 2022 Jan; 50(1):111-121. PubMed ID: 35169091
[TBL] [Abstract] [Full Text] [Related]
13. Distinct DNA Methylation Patterns of Subependymal Giant cell Astrocytomas in Tuberous Sclerosis Complex.
Bongaarts A; Mijnsbergen C; Anink JJ; Jansen FE; Spliet WGM; den Dunnen WFA; Coras R; Blümcke I; Paulus W; Gruber VE; Scholl T; Hainfellner JA; Feucht M; Kotulska K; Jozwiak S; Grajkowska W; Buccoliero AM; Caporalini C; Giordano F; Genitori L; Söylemezoğlu F; Pimentel J; Jones DTW; Scicluna BP; Schouten-van Meeteren AYN; Mühlebner A; Mills JD; Aronica E
Cell Mol Neurobiol; 2022 Nov; 42(8):2863-2892. PubMed ID: 34709498
[TBL] [Abstract] [Full Text] [Related]
14. mTORC1 promotes malignant large cell/anaplastic histology and is a targetable vulnerability in SHH-TP53 mutant medulloblastoma.
Conti V; Cominelli M; Pieri V; Gallotti AL; Pagano I; Zanella M; Mazzoleni S; Pivetta F; Patanè M; Scotti GM; Piras IS; Pollo B; Falini A; Zippo A; Castellano A; Maestro R; Poliani PL; Galli R
JCI Insight; 2021 Dec; 6(23):. PubMed ID: 34673573
[TBL] [Abstract] [Full Text] [Related]
15. [Epithelioid angiomyolipoma of the kidney after successfully treated malignant melanoma].
Rothe H; Gaber A; Dittrich B; Nagel M; Tuffaha M; Hoschke B
Urologe A; 2022 Feb; 61(2):183-186. PubMed ID: 34605930
[TBL] [Abstract] [Full Text] [Related]
16. Pharmacological treatment strategies for subependymal giant cell astrocytoma (SEGA).
Ebrahimi-Fakhari D; Franz DN
Expert Opin Pharmacother; 2020 Aug; 21(11):1329-1336. PubMed ID: 32338549
[TBL] [Abstract] [Full Text] [Related]
17. The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas.
Bongaarts A; van Scheppingen J; Korotkov A; Mijnsbergen C; Anink JJ; Jansen FE; Spliet WGM; den Dunnen WFA; Gruber VE; Scholl T; Samueli S; Hainfellner JA; Feucht M; Kotulska K; Jozwiak S; Grajkowska W; Buccoliero AM; Caporalini C; Giordano F; Genitori L; Coras R; Blümcke I; Krsek P; Zamecnik J; Meijer L; Scicluna BP; Schouten-van Meeteren AYN; Mühlebner A; Mills JD; Aronica E
Brain; 2020 Jan; 143(1):131-149. PubMed ID: 31834371
[TBL] [Abstract] [Full Text] [Related]
18. Ginkgo biloba extract increases neurite outgrowth and activates the Akt/mTOR pathway.
Lejri I; Grimm A; Eckert A
PLoS One; 2019; 14(12):e0225761. PubMed ID: 31790465
[TBL] [Abstract] [Full Text] [Related]
19. Successful treatment of a
Zureick AH; McFadden KA; Mody R; Koschmann C
BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31154346
[TBL] [Abstract] [Full Text] [Related]
20. Dissecting tsc2-mutated renal and hepatic angiomyolipomas in an individual with ARID1B-associated intellectual disability.
Popp B; Agaimy A; Kraus C; Knaup KX; Ekici AB; Uebe S; Reis A; Wiesener M; Zweier C
BMC Cancer; 2019 May; 19(1):435. PubMed ID: 31077186
[TBL] [Abstract] [Full Text] [Related]
[Next]
